Back
Heron Therapeutics Vs. Arcutis Biotherapeutics Industry Stock Comparison
Sell
26
HRTX
Heron Therapeutics
Last Price:
1.75
Seasonality Move:
14.98%
Sell
39
ARQT
Arcutis Biotherapeutics
Last Price:
10.82
Seasonality Move:
47.83%
Sell
26
Heron Therapeutics (HRTX)
is a Sell
Is Heron Therapeutics a Buy, Sell or Hold?
- The current Heron Therapeutics [HRTX] share price is $1.75. The Score for HRTX is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- HRTX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Arcutis Biotherapeutics (ARQT)
is a Sell
Is Arcutis Biotherapeutics a Buy, Sell or Hold?
- The current Arcutis Biotherapeutics [ARQT] share price is $10.82. The Score for ARQT is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- ARQT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
HRTX Stock Price Chart
What is Heron Therapeutics's stock price today?
-
The Heron Therapeutics share price today is $1.75
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HRTX is experiencing slight selling pressure.
ARQT Stock Price Chart
What is Arcutis Biotherapeutics's stock price today?
-
The Arcutis Biotherapeutics share price today is $10.82
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARQT is experiencing slight selling pressure.
HRTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 42.72 | Sell |
| Chaikin Money Flow: | -156794 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.75 - 1.91) | Sell |
| Bollinger Bands (100): | (1.7 - 2.92) | Sell |
ARQT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.1 | Buy |
| Relative Strength Index (14 RSI): | 70.29 | Buy |
| Chaikin Money Flow: | -554078 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.49 - 9.95) | Buy |
| Bollinger Bands (100): | (8.85 - 10.41) | Buy |
HRTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.77 | Sell |
| 20-day SMA: | 1.8 | Sell |
| 50-day SMA: | 1.87 | Sell |
| 200-day SMA: | 2.59 | Sell |
| 8-day EMA: | 1.78 | Sell |
| 20-day EMA: | 1.81 | Sell |
| 50-day EMA: | 1.94 | Sell |
| 200-day EMA: | 2.29 | Sell |
ARQT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.33 | Buy |
| 20-day SMA: | 9.07 | Buy |
| 50-day SMA: | 9.71 | Buy |
| 200-day SMA: | 9.28 | Buy |
| 8-day EMA: | 9.66 | Buy |
| 20-day EMA: | 9.33 | Buy |
| 50-day EMA: | 9.44 | Buy |
| 200-day EMA: | 9.07 | Buy |
Heron Therapeutics Earnings Growth & HRTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.74 per share, and an increase next year of $0.12 per share.
Arcutis Biotherapeutics Earnings Growth & ARQT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.56 per share, and an increase next year of $0.39 per share.
Heron Therapeutics Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Arcutis Biotherapeutics Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||